JPMorgan Assumes Rigel Pharmaceuticals (RIGL) at Overweight

September 26, 2019 6:48 AM EDT Send to a Friend
JPMorgan analyst Tessa Romero assumes primary coverage on Rigel Pharmaceuticals ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login